Matt Barthalow is a Member of the firm and has been with the firm since 2008. He focuses his practice primarily on patent prosecution and client counseling, including performing due diligence analyses for contemplated business transactions and preparing opinions on infringement and validity issues, including freedom-to-operate opinions prior to product launches. Matt has extensive experience working with a wide range of technologies, but concentrates his prosecution and client-counseling practice primarily on chemical, pharmaceutical, and biotechnology patent matters. In this respect, he is the point person for the firm's biotechnology/biopharmaceutical practice.
Matt has provided lectures and seminars on aspects of U.S. patent law and practice, including while traveling in France, Japan, and India. He also devotes significant time to mentoring new attorneys at the firm. During law school, Matt was an extern at the USPTO's Office of the Solicitor where he had the opportunity to work on projects related to both legal policy and appellate advocacy. Prior to law school, he performed scientific research during graduate school and at the National Cancer Institute (NCI) while an undergraduate.
Bayer AG v Housey Pharmaceuticals: Protection for Biotechnological Research Tools under Section 271(f) Found Wanting, published at 4 Pierce L. Rev. 9 (2005)